Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-16-014988

Chief Operating Officer sold 457 shares at $3.53 ($1,613)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Keuer Thomas A Chief Operating Officer 2016-03-01 Sale −457 $3.53 $1,613 16,481 D
Open-market sales · 457 sh · avg $3.53 · $1,613
Loading xslF345X03/doc4.xml…